Cargando…
Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis
BACKGROUND: Adrenal suppression (AS), a glucocorticoid (GC) side effect associated with significant morbidity, is well described related to inhaled corticosteroid therapy for asthma. Swallowed topical glucocorticoid therapy is the main pharmacotherapy treatment for eosinophilic esophagitis (EoE) and...
Autores principales: | Ahmet, Alexandra, Benchimol, Eric I., Goldbloom, Ellen B., Barkey, Janice L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057375/ https://www.ncbi.nlm.nih.gov/pubmed/27766109 http://dx.doi.org/10.1186/s13223-016-0154-9 |
Ejemplares similares
-
Budesonide and fluticasone and adrenal suppression
por: Fouda, Mona A, et al.
Publicado: (2012) -
Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis
por: Numan, Laith, et al.
Publicado: (2023) -
A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis
por: Oliva, Salvatore, et al.
Publicado: (2019) -
A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
por: Warzecha, Joanna, et al.
Publicado: (2022) -
Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
por: Gupta, Sandeep K., et al.
Publicado: (2022)